Cite
HARVARD Citation
Guo, W. et al. (2019). Systemic immune‐inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non‐small cell lung cancer. Thoracic cancer. 10 (4), pp. 761-768. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Guo, W. et al. (2019). Systemic immune‐inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non‐small cell lung cancer. Thoracic cancer. 10 (4), pp. 761-768. [Online].